Vorasidenib-Induced Trichomegaly and Hypertrichosis: a New Side Effect in a Patient with Diffuse Astrocytoma
Abstract Vorasidenib, an oral dual inhibitor targeting mutant enzymes isocitrate dehydrogenase 1 and 2, is utilized in the management of diffuse low-grade gliomas. Despite limited documentation of its adverse events, we present the case of a 44-year-old male who exhibited trichomegaly and hypertrich...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Adis, Springer Healthcare
2024-08-01
|
| シリーズ: | Dermatology and Therapy |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1007/s13555-024-01263-4 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|